Search

Brenda K Minesinger

from Tewksbury, MA
Age ~51
Get Report
Also known as:
Brenda K Devlin
Related to:
Benjamin K DevlinRobert H Keller, 52Jonathan RossTyonna Jones, 34Brent RossLanny Ross, 82
Connected to:
Susan G Minesinger, 63Connie Miness, 79Buffi M Minet, 51Kathleen M Minet, 60Richard K Minet, 80Patrick P Minetola, 85Costas G Minetos, 46Carol H Minetree, 77Jennifer I Minett, 42Jimmie Minett, 96

Brenda Minesinger Phones & Addresses

  • Tewksbury, MA
  • Keystone Heights, FL
  • 46 Cedar St, Somerville, MA 02143 (617) 666-3420
  • McDonough, GA
  • Gainesville, FL
  • Decatur, GA
  • 18 Pupkis Rd, Tewksbury, MA 01876 (912) 660-8953

Work

Company: Intellia therapeutics, inc. Dec 2016 Position: Principal scientist

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Emory University 1998 to 2004 Specialities: Biochemistry, Biology

Skills

Molecular Biology • Western Blotting • Protein Purification • Molecular Genetics • Biochemistry • Microbiology • Drug Discovery • Recombinant Dna Technology • Assay Development • Genetics • Pcr • Protein Engineering • Sequencing • Rna Isolation • Dna Extraction • Public Speaking • Seamless Cloning • Vector Construction • Mutagenesis • Qpcr • High Throughput Screening • Cell Culture • Teamwork • Molecular Cloning • Protein Protein Interactions • Immunoprecipitation • Mentoring • Biotechnology • Life Sciences • Genomics • Antibodies • Supervisory Experience • Collaborative Problem Solving • Safety Management • Deadline Oriented • Cell Biology • Protein Expression • Leadership • Fluorescence Microscopy

Languages

English

Industries

Biotechnology

Resumes

Resumes

Brenda Minesinger Photo 1

Principal Scientist

View page
Location:
25 Chuckies Way, Tewksbury, MA 01876
Industry:
Biotechnology
Work:
Intellia Therapeutics, Inc.
Principal Scientist
Fluid-Screen Aug 2016 - Nov 2016
Independent Contractor
Biogen Sep 2013 - Nov 2015
Scientist I
Massachusetts Institute of Technology (Mit) Jan 2012 - Aug 2013
Research Scientist
Massachusetts Institute of Technology (Mit) Sep 2005 - Dec 2011
Postdoctoral Associate and Fellow
Education:
Emory University 1998 - 2004
Doctorates, Doctor of Philosophy, Biochemistry, Biology University of Florida 1994 - 1996
Bachelors, Bachelor of Science, Microbiology Santa Fe Community College 1991 - 1993
Skills:
Molecular Biology
Western Blotting
Protein Purification
Molecular Genetics
Biochemistry
Microbiology
Drug Discovery
Recombinant Dna Technology
Assay Development
Genetics
Pcr
Protein Engineering
Sequencing
Rna Isolation
Dna Extraction
Public Speaking
Seamless Cloning
Vector Construction
Mutagenesis
Qpcr
High Throughput Screening
Cell Culture
Teamwork
Molecular Cloning
Protein Protein Interactions
Immunoprecipitation
Mentoring
Biotechnology
Life Sciences
Genomics
Antibodies
Supervisory Experience
Collaborative Problem Solving
Safety Management
Deadline Oriented
Cell Biology
Protein Expression
Leadership
Fluorescence Microscopy
Languages:
English

Publications

Us Patents

Nuclease Compositions And Methods

View page
US Patent:
20100222410, Sep 2, 2010
Filed:
Jul 17, 2009
Appl. No.:
12/460446
Inventors:
Bryan W. Davies - Allston MA, US
Caroline Koehrer - Somerville MA, US
Asha I. Jacob - Somerville MA, US
Uttam L. RajBhandary - Lexington MA, US
Graham C. Walker - Cambridge MA, US
Brenda Kathleen Minesinger - Somerville MA, US
Shree Prakash Pandey - Boston MA, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 31/7088
C12N 9/48
G01N 33/554
A61K 31/165
A61K 31/546
A61K 31/13
A61K 31/4164
A61K 31/421
A61K 31/426
A61K 31/18
A61P 31/04
US Classification:
514 44 A, 435212, 435 732, 514620, 514207, 514662, 514386, 514378, 514370, 514604
Abstract:
The present invention generally relates to various nucleases and uses thereof, and in some cases, to the UPF0054 protein superfamily. Members of the UPF0054 protein superfamily, such as the protein YbeY, may possess RNase activity and may be involved in certain important cellular processes. Disruption of YbeY activity can lead to increased sensitivity to antibiotics. Accordingly, certain embodiments of the invention are directed to systems and methods for screening target compounds for activity against UPF0054 superfamily proteins. In some embodiments, the screening method allows to target compositions to be determined that show selective activity against UPF0054 superfamily proteins. Other embodiments of the invention provide for nucleases capable of site-specific cleavage of nucleic acids.

Dkk2 Cysteine Rich Domain 2 Containing Proteins And Uses Thereof

View page
US Patent:
20200270335, Aug 27, 2020
Filed:
Dec 16, 2016
Appl. No.:
16/063423
Inventors:
- Cambridge MA, US
Richelle Sopko - Brookline MA, US
Joshua Mugford - Waltham MA, US
Andreas Lehmann - Belmont MA, US
Joseph W. Arndt - Swampscott MA, US
Nels E. Pederson - Mansfield MA, US
Brenda K. Minesinger - Tewksbury MA, US
International Classification:
C07K 16/18
A61K 47/65
C07K 14/765
Abstract:
Proteins containing a DKK2 polypeptide or a fragment or variant thereof are described. These proteins contain human serum albumin sequences and/or include substitutions in the DKK2 polypeptide that decrease heparin binding. These proteins are useful in the treatment of disorders such as acute kidney injury and fibrosis.
Control profile
Brenda K Minesinger from Tewksbury, MA, age ~51 Get Report